510(k) Report

510(k) · Cleared

Cleared

Oxyvu -1 Hyperspectral Tissue Oxygenation (Hto) Measurement System

K073656510(k) SpecialCleared Jan 25, 200830-day reviewClass II21 CFR 870.2700

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Hypermed, Inc. · MUD Oximeter, Tissue Saturation

Cleared on Jan 25, 2008 as substantially equivalent to K061848 (Hypermed, Inc., 2006) after a 30-day review. Its family tree reaches back 6 generations to 1998. 8 later devices descend from it.

Decided
Jan 25, 2008
Review
30 days
Class
Class II
Product code
MUD
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K963903 (1998). 8 later devices descend from it, 3 citing it directly.

  1. Root · 6 generations backK963903 Biospectrometer-NB Oximeter IiiiHutchinson Technology, Inc. · 1998
  2. 5 generations backK012759 Inspectra Tissue Spectrometer System (Inspectra), Model 325Hutchinson Technology, Inc. · 2002
  3. 4 generations backK023938 Modification to Inspectra Tissue Spectrometer System, Model 325Hutchinson Technology, Inc. · 2002
  4. 3 generations backK042020 Spectra Tissue Spectrometer System (Inspectra)Hutchinson Technology, Inc. · 2004
  5. 2 generations backK053618 Inspectra Tissue Spectrometer System, Model 325Hutchinson Technology, Inc. · 2006
  6. 1 generation backK061848 Hyperspectral Tissue Oxygenation Measurement System, Model Oxy VU1Hypermed, Inc. · 2006
  7. This deviceK073656 Oxyvu -1 Hyperspectral Tissue Oxygenation (Hto) Measurement SystemHypermed, Inc. · 2008
  8. Descendant · cites it directly · 3 of its ownK113507 Kent CameraKent Imaging, Inc. · 2012
  9. Descendant · cites it directly · 2 of its ownK153426 Ox-Imager CSModulated Imaging, Inc. · 2016
  10. Descendant · 2 generations on · 1 of its ownK181623 Clarifi Imaging SystemModulated Imaging, Inc. · 2018
  11. Descendant · 2 generations on · 1 of its ownK163070 Kent CameraKent Imaging, Inc. · 2017
  12. Descendant · 3 generations on · 0 of its ownK254129 Spectrum-2Neko Health AB · 2026

Showing 5 of 8 descendants. See all descendants

Descendants cleared per year

2012: 12016: 22017: 12018: 22020: 12026: 1
2012high 2 (2016) · low 0 (2013)2026

Most influential descendants

Showing 5 of 8 · See all
  • K113507Kent CameraKent Imaging, Inc. · 2012 · cites it directly3descendants
  • K153426Ox-Imager CSModulated Imaging, Inc. · 2016 · cites it directly2descendants
  • K181623Clarifi Imaging SystemModulated Imaging, Inc. · 2018 · 2 generations on1descendant
  • K163070Kent CameraKent Imaging, Inc. · 2017 · 2 generations on1descendant
  • K254129Spectrum-2Neko Health AB · 2026 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K963903Biospectrometer-NB Oximeter IiiiHutchinson Technology, Inc.1998—
−5K012759Inspectra Tissue Spectrometer System (Inspectra), Model 325Hutchinson Technology, Inc.2002—
−4K023938Modification to Inspectra Tissue Spectrometer System, Model 325Hutchinson Technology, Inc.2002—
−3K042020Spectra Tissue Spectrometer System (Inspectra)Hutchinson Technology, Inc.2004—
−2K053618Inspectra Tissue Spectrometer System, Model 325Hutchinson Technology, Inc.2006—
−1K061848Hyperspectral Tissue Oxygenation Measurement System, Model Oxy VU1Hypermed, Inc.2006—
0 (this device)K073656Oxyvu -1 Hyperspectral Tissue Oxygenation (Hto) Measurement SystemHypermed, Inc.2008—
+1K113507Kent CameraKent Imaging, Inc.2012—
+1K153426Ox-Imager CSModulated Imaging, Inc.2016—
+2K181623Clarifi Imaging SystemModulated Imaging, Inc.2018—
+2K163070Kent CameraKent Imaging, Inc.2017—
+3K254129Spectrum-2Neko Health AB2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201210
201620
201710
201820
202010
202610
FIG. 1 — Lineage of K073656, 1998–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MUD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MUD device

  1. #1 K223651 Cerebral Adaptive Index (CAI) Algorithmscore 19.8 · 29 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K061848Hyperspectral Tissue Oxygenation Measurement System, Model Oxy VU1
Summary page 1
…Product Code: MUD Substantial Equivalence The OxyVuTM-I system is substantially equivalent to the OxyVuTM-I system cleared in 5 10(k) K061848. Device Description The OxyVuTM-1 system is based on hyperspectral imaging technology. The technology performs…
Hypermed, Inc.2006—

Also cleared against K061848: 1 other device →

What descends from it? (8)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K113507Kent CameraKent Imaging, Inc.20123
K153426Ox-Imager CSModulated Imaging, Inc.20162
K161237HyperView Hyperspectral Tissue Oxygenation Measurement SystemHypermed Imaging, Inc.20160

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 10 years and passes through 2 companies; a new generation was cleared every 1.4 years on median.
  • None of the 6 ancestors has a recall.
  • Of its descendants, K113507 (Kent Imaging, Inc., 2012) has gone furthest, with 3 descendants of its own.
  • 1 other device also cites its predicate K061848.

How does its category compare?

All MUD devices

MUD Oximeter, Tissue Saturation: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · MUD

2in 2025

2008: 42009: 42010: 42011: 22012: 62013: 22014: 52015: 32016: 42017: 32018: 32019: 72020: 22021: 22022: 22023: 22024: 52025: 22026 (partial year): 1
2007high 7 (2019) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MUD

124in 2024

2008: 72 days median2009: 96 days median2010: 59 days median2012: 211 days median2014: 109 days median2015: 107 days median2016: 167 days median2017: 249 days median2018: 128 days median2019: 88 days median2024: 124 days median
2007high 249 (2017) · low 59 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MUD

1in 2023

2009: 12022: 22023: 12026 (partial year): 1
2007high 2 (2022) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MUD

131in 2025

2008: 22009: 72010: 12011: 22012: 32013: 82014: 42016: 92017: 242018: 382019: 1072020: 502021: 272022: 522023: 732024: 1402025: 131
2007high 140 (2024) · low 0 (2007)2025

MAUDE reports naming product code MUD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
200847202
200949617
201045901
20112—02
2012621103
20132—08
2014510904
2015310700
2016416709
20173249024
20183128038
20197880107
20202—050
20212—027
20222—252
20232—173
202451240140
20252—0131
20261—1—

What is it indicated for?

The OxyVuTM-l Hyperspectral Tissue Oxygenation (HTO) Measurement System is intended for use by healthcare professionals as a non-invasive tissue oxygenation measurement system that reports an approximate value of:

• oxygen saturation (HT-Sat),

* oxyhemoglobin level (HT-Oxy), and

· deoxyhemoglobin (HT-Deoxy) level

in superficial tissue. The OxyVuTM-1 system displays two-dimensional color-coded images of tissue oxygenation of the scanned surface and reports hyperspectral tissue oxygenation measurements for selected tissue regions.

The OxyVuTM-I system is indicated for use to determine oxygenation levels in superficial tissues for patients with potential circulatory compromise.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K073656: Oxyvu -1 Hyperspectral Tissue Oxygenation (Hto) Measurement System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K073656

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026